This finding is corroborated by several studies: Sitoe et al. [29] demonstrated that plasma S100A8 levels significantly decreased during the course of tuberculosis treatment, Jiang et al. [30] confirmed that S100A8 is the best biomarker for distinguishing between active and latent tuberculosis, while Muefong et al. [31] further established that S100A8 levels are significantly correlated with neutrophil counts and the degree of lung damage. This evidence concerns the gene S100A8 and tuberculosis.